Skip to main content
Signal8

HUME DANIEL

SEC insider (Form 3/4/5 filer). CIK 0001645514. Director at TG THERAPEUTICS, INC. (TGTX) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in MORRISVILLE, NC.

Companies HUME DANIEL has filed insider reports for

  • TG THERAPEUTICS, INC. (TGTX): Director
  • Insight Digital Partners II (DYOR): Director
HUME DANIEL profile photo

HUME DANIEL

CIK: 0001645514

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TG THERAPEUTICS, INC. logo
TGTX

TG THERAPEUTICS, INC.

Director
Insight Digital Partners II logo
DYOR

Insight Digital Partners II

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • TG THERAPEUTICS, INC. logo
    TGTX

    TG THERAPEUTICS, INC.

    Jun 11, 2026
    Award

    Stock Tracking Unit

    Direct
    8.3K shares-
  • TG THERAPEUTICS, INC. logo
    TGTX

    TG THERAPEUTICS, INC.

    Jun 12, 2025
    Award
    Direct
    14.7K shares-
  • TG THERAPEUTICS, INC. logo
    TGTX

    TG THERAPEUTICS, INC.

    Mar 17, 2025
    Gift
    Direct
    62.5K shares-

1-3 of 3